发明名称 |
CD19 BINDING AGENTS AND USES THEREOF |
摘要 |
This invention, inter alia, relates to CD19 binding agents and methods of using such CD19 binding agents for treating disease. |
申请公布号 |
US2015283255(A1) |
申请公布日期 |
2015.10.08 |
申请号 |
US201514743318 |
申请日期 |
2015.06.18 |
申请人 |
Seattle Genetics, Inc. |
发明人 |
McDonagh Charlotte;Cerveny Charles G.;Benjamin Dennis;Carter Paul |
分类号 |
A61K47/48;A61K38/05;C07K16/30 |
主分类号 |
A61K47/48 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for treating a CD19-associated disorder in a mammalian subject comprising administering an antibody or antigen-binding fragment that specifically binds to human CD19 in an amount effective to treat the disorder in the mammalian subject; the antibody or antigen-binding fragment comprising a heavy chain variable region amino acid sequence as set forth in SEQ ID NO:29 with 0, 1 or 2 substitutions relative to SEQ ID NO:9 and a light chain variable region amino acid sequence as set forth in SEQ ID NO:30 with 0, 1 or 2 substitutions relative to SEQ ID NO:17; wherein the antibody or antigen-binding fragment binds to CD19 with a dissociation constant of 1×10−7 M. |
地址 |
Bothell WA US |